Nanox Imaging Ltd. (NASDAQ: NNOX) announced a distribution agreement with Costa Rica-based medical equipment distributor SOLME RC, S.A. to market and support the Nanox.ARC, a multi-source digital tomosynthesis system designed to expand access to 3D medical imaging. The agreement grants SOLME responsibility for marketing, distribution, installation, training, and ongoing technical support in Costa Rica. SOLME is a registered supplier to the Caja Costarricense de Seguro Social (CCSS), the country's principal purchaser and provider of hospital services. Commercialization will proceed following applicable regulatory registration, including an initial six-month proof-of-concept device registration period before full registration. Costa Rica represents Nanox's third Latin American market this year, following Argentina and Peru. To view the full press release, visit https://ibn.fm/C77lJ.
The agreement matters because it extends Nanox's reach into a new national healthcare system, potentially accelerating the adoption of its cost-effective 3D imaging technology in a region where access to advanced medical imaging can be limited. By partnering with SOLME, which already supplies the CCSS, Nanox gains a direct channel to Costa Rica's public hospital network. This could lead to broader utilization of the Nanox.ARC and support earlier detection of disease, aligning with Nanox's vision of driving the world's transition to preventive health care. The proof-of-concept registration period suggests a phased approach, allowing for clinical validation before full-scale deployment. If successful, this model could be replicated in other markets, furthering Nanox's goal to lower barriers to adoption and improve patient outcomes through its integrated imaging ecosystem.
Nanox (NASDAQ: NNOX) focuses on delivering an end-to-end medical imaging and healthcare services platform that combines affordable imaging hardware, AI-based solutions, cloud-based software, remote radiology, health IT solutions, and a marketplace. The Nanox ecosystem includes Nanox.ARC, Nanox.AI, Nanox.CLOUD, Nanox.MARKETPLACE, USARAD Holdings, and Nanox Health IT. By integrating these components, Nanox seeks to enhance routine imaging workflows, support early detection, and expand access to care both within and beyond traditional hospital settings. The latest news and updates relating to NNOX are available in the company's newsroom at http://ibn.fm/NNOX. BioMedWire is a specialized communications platform focused on the Biotechnology, Biomedical Sciences, and Life Sciences sectors, and is one of 75+ brands within the Dynamic Brand Portfolio @ IBN. For more information, visit https://www.BioMedWire.com.
